Teva Unit Recalls Cancer Drug Treanda Over Glass Fragments

Law360, New York (January 27, 2012, 7:56 PM EST) -- Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. will voluntarily recall a batch of its leukemia drug Treanda after glass fragments were found in one of its vials, Teva said Friday.

Frazer, Pa.-based Cephalon recalled a production lot of Treanda’s 25mg/8mL injections, used to treat chronic lymphocytic leukemia and a certain type of non-Hodgkin’s lymphoma, Teva said in a statement.

The lot was distributed across the U.S. from March to October, Teva said, stating that it had informed recipients of the batch including retailers, wholesalers and hospitals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.